Author response: La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

Roni M. Lahr, Andrea J. Berman(University of Pittsburgh), Hiba A. Al-Ashtal(University of Pittsburgh), Sarah P. Blagden(Churchill Hospital), Gabrielle E. Ciotti(University of Pittsburgh), Tommy Alain(University of Ottawa), Jianjun Jia(Children's Hospital of Eastern Ontario), Bruno D. Fonseca(University of British Columbia), Marius Niklaus(University of Würzburg)
Unknown
March 27, 2017
10.7554/elife.24146.025
Cited by 3

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
|Nature Communications|2020|458
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial
|The Lancet|2019|223
Performance status score: do patients and their oncologists agree?
|British Journal of Cancer|2003|222
La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs
|eLife|2017|201